Your Search Returned 1 tagged news report
A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options...Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (
Tags: